G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review
Kim Campbell, Edward Li(Sanden (Japan)), Nidhi Chadha(Novartis (India)), Seema Dimri(Sanden (Japan)), Weijia Wang(Novartis (United States))
Cited by 14
Related Papers
Synergistic Function of E2F7 and E2F8 Is Essential for Cell Survival and Embryonic Development
|Developmental Cell|2008|231
Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death
|The Journal of Cell Biology|2017|175
Characterizing the demographics of chronic pain patients in the state of Maine using the Maine all payer claims database
|BMC Public Health|2018|85
Projecting future drug expenditures—2012
|American Journal of Health-System Pharmacy|2012|81
The Role of the CD40 Pathway in Alloantigen-Induced Hyporesponsiveness In Vivo
|The Journal of Immunology|1998|79